BCHE and dementia: Cholinesterase inhibitors and memantine provide modest but clinically relevant benefits in established dementia, yet in MCI their effects are weaker, short-lived, and often difficult to distinguish from test–retest variability, including practice effects, especially when functional outcomes and conversion to dementia are considered [27,28,29,30,31,32,33,34,35,36,37].